THERALINK TECHNOLOGIES, INC. Quarterly Return On Equity in % from Q2 2012 to Q4 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Theralink Technologies, Inc. quarterly/annual Return On Equity history and growth rate from Q2 2012 to Q4 2023.
  • Theralink Technologies, Inc. Return On Equity for the quarter ending December 31, 2023 was 27.7 %, a 91.3% decline year-over-year.
  • Theralink Technologies, Inc. annual Return On Equity for 2023 was 67.8 %, a 72.5% decline from 2022.
  • Theralink Technologies, Inc. annual Return On Equity for 2022 was 246 %, a 49.8% increase from 2021.
  • Theralink Technologies, Inc. annual Return On Equity for 2021 was 164 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2023 27.7 -290 -91.3% Oct 1, 2023 Dec 31, 2023
Q3 2023 67.8 -178 -72.5% Jul 1, 2023 Sep 30, 2023
Q2 2023 128 -10.7 -7.72% Apr 1, 2023 Jun 30, 2023
Q1 2023 201 +59.8 +42.5% Jan 1, 2023 Mar 31, 2023
Q4 2022 317 +182 +134% Oct 1, 2022 Dec 31, 2022
Q3 2022 246 +81.8 +49.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 138 -108 -43.8% Apr 1, 2022 Jun 30, 2022
Q1 2022 141 -327 -69.9% Jan 1, 2022 Mar 31, 2022
Q4 2021 136 +3.04K Oct 1, 2021 Dec 31, 2021
Q3 2021 164 +492 Jul 1, 2021 Sep 30, 2021
Q2 2021 246 +565 Apr 1, 2021 Jun 30, 2021
Q1 2021 467 +1.38K Jan 1, 2021 Mar 31, 2021
Q4 2020 -2.9K -3.41K -673% Oct 1, 2020 Dec 31, 2020
Q3 2020 -328 -530 -262% Jul 1, 2020 Sep 30, 2020
Q2 2020 -319 -483 -295% Apr 1, 2020 Jun 30, 2020
Q1 2020 -916 -1.11K -582% Jan 1, 2020 Mar 31, 2020
Q4 2019 507 +590 Oct 1, 2019 Dec 31, 2019
Q3 2019 202 +105 +108% Jul 1, 2019 Sep 30, 2019
Q2 2019 164 +9.94 +6.47% Apr 1, 2019 Jun 30, 2019
Q1 2019 190 +34.4 +22.1% Jan 1, 2019 Mar 31, 2019
Q4 2018 -83.2 -647 -115% Oct 1, 2018 Dec 31, 2018
Q3 2018 97 -6.65K -98.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 154 +732 Apr 1, 2018 Jun 30, 2018
Q1 2018 156 +5.08K Jan 1, 2018 Mar 31, 2018
Q4 2017 564 -34.7 -5.8% Oct 1, 2017 Dec 31, 2017
Q3 2017 6.74K +29.7K Jul 1, 2017 Sep 30, 2017
Q2 2017 -579 +1.6K +73.4% Apr 1, 2017 Jun 30, 2017
Q1 2017 -4.93K -4.08K -481% Jan 1, 2017 Mar 31, 2017
Q4 2016 598 -106 -15.1% Oct 1, 2016 Dec 31, 2016
Q3 2016 -23K -23.2K -10658% Jul 1, 2016 Sep 30, 2016
Q2 2016 -2.18K -2.29K -2054% Apr 1, 2016 Jun 30, 2016
Q1 2016 -848 -933 -1101% Jan 1, 2016 Mar 31, 2016
Q4 2015 704 +541 +331% Oct 1, 2015 Dec 31, 2015
Q3 2015 218 +53 +32.2% Jul 1, 2015 Sep 30, 2015
Q2 2015 112 -152 -57.7% Apr 1, 2015 Jun 30, 2015
Q1 2015 84.8 -555 -86.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 163 +1.98K Sep 1, 2014 Nov 30, 2014
Q3 2014 165 +1K Jul 1, 2014 Sep 30, 2014
Q2 2014 264 +281 Mar 1, 2014 May 31, 2014
Q1 2014 640 +714 Dec 1, 2013 Feb 28, 2014
Q4 2013 -1.81K -1.89K -2561% Sep 1, 2013 Nov 30, 2013
Q3 2013 -839 -954 -827% Jun 1, 2013 Aug 31, 2013
Q2 2013 -17.7 +428 +96% Mar 1, 2013 May 31, 2013
Q1 2013 -74.2 Dec 1, 2012 Feb 28, 2013
Q4 2012 73.7 Sep 1, 2012 Nov 30, 2012
Q3 2012 115 Jun 1, 2012 Aug 31, 2012
Q2 2012 -446 Mar 1, 2012 May 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.